TG Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.About TGTX
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.
TGTX Key Statistics
Stock Snapshot
TG Therapeutics(TGTX) stock is priced at $53.93, giving the company a market capitalization of 8.25B. It carries a P/E multiple of 19.64.
As of 2026-08-30, TG Therapeutics(TGTX) stock has fluctuated between $53.80 and $55.80. The current price stands at $53.93, placing the stock +0.2% above today's low and -3.4% off the high.
TG Therapeutics(TGTX) shares are trading with a volume of 1.03M, against a daily average of 1.96M.
In the last year, TG Therapeutics(TGTX) shares hit a 52-week high of $59.30 and a 52-week low of $26.76.
In the last year, TG Therapeutics(TGTX) shares hit a 52-week high of $59.30 and a 52-week low of $26.76.
TGTX News
...
TG Therapeutics (TGTX) announced an update on their ongoing clinical study. TG Therapeutics, Inc. has launched a Phase 2 study called “Evaluating Safety and Ef...
Analyst ratings
89%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.